MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
Maturities and sales of marketab...
Proceeds from the revenue share ...
Equity-based compensation expens...
Others
Negative Cash Flow Breakdown
Purchases of marketable securiti...
Prepaid expenses and other curre...
Other non-current assets
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Net loss
-85,854
-74,111
-69,387
-65,021
Depreciation expense
409
408
406
406
Equity-based compensation expense
16,663
17,155
11,930
11,877
Amortization of discounts on marketable securities
1,741
1,549
1,742
1,620
Non-cash lease expense
999
980
959
940
Non-cash interest expense
1,580
-
-
-
Loss on disposal of property and equipment
-43
-
-
-
Prepaid expenses and other current assets
6,134
2,490
-1,642
2,106
Other non-current assets
2,091
-155
-73
181
Accounts payable
1,843
16
845
-5,302
Operating lease liability
-1,214
-802
-1,004
-992
Accrued expenses
4,117
4,668
-6,411
7,744
Net cash used in operating activities
-71,380
-55,570
-62,689
-54,255
Purchases of marketable securities
552,752
183,244
389,088
107,632
Maturities and sales of marketable securities
170,883
147,895
100,524
125,577
Purchases of property and equipment
-
-
62
0
(purchase) sale of property and equipment
-6
-
-
-
Net cash (used in) provided by investing activities
-381,863
-35,349
-288,626
17,945
Proceeds from issuance of common stock and pre-funded warrants, net of issuance costs
-
-
324,052
-
Proceeds from issuance of common stock, net of issuance costs
-728
378,169
-
0
Proceeds from issuance of common stock under atm equity offering program, net of issuance costs
-
-
65,582
-
Proceeds from issuance of common stock under the atm facility, net of issuance costs
0
9,552
-
19,382
Proceeds from exercise of options and employee stock purchase plan purchases
14,059
-
4,698
356
Proceeds from exercise of options
-
4,064
-
-
Proceeds from the revenue share agreement (as defined below), net of debt issuance costs
97,750
-
-
-
Net cash provided by financing activities
107,017
411,167
374,950
19,738
Decrease in cash, cash equivalents and restricted cash
-346,226
320,248
23,635
-16,572
Cash, cash equivalents and restricted cash, beginning of period
451,797
131,549
107,914
142,083
Cash, cash equivalents and restricted cash, end of period
105,571
-
-
-
Issuance of common stock upon exercise of stock options for which proceeds had not yet been received
17
-
-
-
Cash and cash equivalents
105,571
-
-
-
Total
105,571
451,797
131,549
107,914
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Proceeds from the revenue
share agreement (as...
$97,750K
Proceeds from exercise of
options and employee...
$14,059K
(680.19%↑ Y/Y)
Net cash provided by
financing activities
$107,017K
(5838.79%↑ Y/Y)
Canceled cashflow
$728K
Decrease in cash, cash
equivalents and restricted...
-$346,226K
(-1867.53%↓ Y/Y)
Canceled cashflow
$107,017K
Maturities and sales of
marketable securities
$170,883K
(-29.32%↓ Y/Y)
(purchase) sale of property
and equipment
-$6K
Equity-based compensation
expense
$16,663K
(-25.84%↓ Y/Y)
Accrued expenses
$4,117K
(271.04%↑ Y/Y)
Accounts payable
$1,843K
(-60.00%↓ Y/Y)
Non-cash interest
expense
$1,580K
Non-cash lease expense
$999K
(-43.81%↓ Y/Y)
Depreciation expense
$409K
(-32.51%↓ Y/Y)
Loss on disposal of
property and equipment
-$43K
Proceeds from issuance of
common stock, net of...
-$728K
Net cash (used in)
provided by investing...
-$381,863K
(-519.14%↓ Y/Y)
Canceled cashflow
$170,889K
Net cash used in
operating activities
-$71,380K
(35.41%↑ Y/Y)
Canceled cashflow
$25,654K
Purchases of marketable
securities
$552,752K
(279.69%↑ Y/Y)
Net loss
-$85,854K
(29.30%↑ Y/Y)
Prepaid expenses and
other current assets
$6,134K
(273.57%↑ Y/Y)
Other non-current
assets
$2,091K
(-74.99%↓ Y/Y)
Amortization of discounts on
marketable securities
$1,741K
(-57.94%↓ Y/Y)
Operating lease liability
-$1,214K
(38.84%↑ Y/Y)
Buy us a coffee
Apogee Therapeutics, Inc. (APGE)
Apogee Therapeutics, Inc. (APGE)